173 related articles for article (PubMed ID: 27488345)
1. Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives.
De Jaco A; Bernardini L; Rosati J; Tata AM
Cent Nerv Syst Agents Med Chem; 2017; 17(2):100-108. PubMed ID: 27488345
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
Shen J; Wu J
Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
[TBL] [Abstract][Full Text] [Related]
3. The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system.
Koukouli F; Maskos U
Biochem Pharmacol; 2015 Oct; 97(4):378-387. PubMed ID: 26206184
[TBL] [Abstract][Full Text] [Related]
4. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.
Wallace TL; Porter RH
Biochem Pharmacol; 2011 Oct; 82(8):891-903. PubMed ID: 21741954
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic Modulation of Neuroinflammation: Focus on α7 Nicotinic Receptor.
Piovesana R; Salazar Intriago MS; Dini L; Tata AM
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066354
[TBL] [Abstract][Full Text] [Related]
6. Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer's Dimer.
Hu S; Cui W; Mak S; Xu D; Hu Y; Tang J; Choi C; Lee M; Pang Y; Han Y
ACS Chem Neurosci; 2015 Sep; 6(9):1536-45. PubMed ID: 26147504
[TBL] [Abstract][Full Text] [Related]
7. Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia.
Wallace TL; Bertrand D
Int Rev Neurobiol; 2015; 124():79-111. PubMed ID: 26472526
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
Farhat SM; Ahmed T
Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
Levin ED; McClernon FJ; Rezvani AH
Psychopharmacology (Berl); 2006 Mar; 184(3-4):523-39. PubMed ID: 16220335
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.
Maelicke A; Albuquerque EX
Eur J Pharmacol; 2000 Mar; 393(1-3):165-70. PubMed ID: 10771010
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3.
Mizrachi T; Vaknin-Dembinsky A; Brenner T; Treinin M
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684720
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
[TBL] [Abstract][Full Text] [Related]
13. Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum.
Guerra-Álvarez M; Moreno-Ortega AJ; Navarro E; Fernández-Morales JC; Egea J; López MG; Cano-Abad MF
J Neurochem; 2015 May; 133(3):309-19. PubMed ID: 25650007
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacology of memory consolidation and reconsolidation: Insights on central cholinergic mechanisms.
Blake MG; Krawczyk MC; Baratti CM; Boccia MM
J Physiol Paris; 2014; 108(4-6):286-91. PubMed ID: 24819880
[TBL] [Abstract][Full Text] [Related]
15. N-Stearoylethanolamine protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of α7 nicotinic acetylcholine receptor.
Lykhmus O; Uspenska K; Koval L; Lytovchenko D; Voytenko L; Horid'ko T; Kosiakova H; Gula N; Komisarenko S; Skok M
Int Immunopharmacol; 2017 Nov; 52():290-296. PubMed ID: 28963942
[TBL] [Abstract][Full Text] [Related]
16. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats.
Nikiforuk A; Kos T; Potasiewicz A; Popik P
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1300-13. PubMed ID: 26003081
[TBL] [Abstract][Full Text] [Related]
17. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
Kamkwalala AR; Newhouse PA
Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
[TBL] [Abstract][Full Text] [Related]
18. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.
Maelicke A
Dement Geriatr Cogn Disord; 2000 Sep; 11 Suppl 1():11-8. PubMed ID: 10971047
[TBL] [Abstract][Full Text] [Related]
19. The Cholinergic System: An Emerging Drug Target for Schizophrenia.
Gibbons A; Dean B
Curr Pharm Des; 2016; 22(14):2124-33. PubMed ID: 26818859
[TBL] [Abstract][Full Text] [Related]
20. [A role of alpha-7 nicotinic acetylcholine receptors in pharmacotherapy of neurodegenerative diseases].
Makotrova TA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10 Pt 2):57-9. PubMed ID: 23250612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
